Small Cap Stocks in Spotlight: AMD, DUF, HOV, ARR, ARNA

Houston, TX -- (SBWIRE) -- 01/02/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.

Advanced Micro Devices, Inc. (NYSE:AMD) is currently trading at $2.31, 1.27% higher. Advanced Micro Devices, Inc. (AMD) is a global semiconductor company with facilities globally. Within the global semiconductor industry, it offers x86 microprocessors, as standalone devices or as incorporated as an accelerated processing unit, for the commercial and consumer markets, embedded microprocessors for commercial, commercial client and consumer markets and chipsets for desktop and mobile devices, including mobile personal computers (PCs), and tablets, professional workstations and servers, and graphics, video and multimedia products for desktop and mobile devices, including mobile PCs and tablets, home media PCs and professional workstations, servers and technology for game consoles.

How Should Investors Trade AMD After The Recent Volatile Moves? Find Out Here

Duff & Phelps Corp (NYSE:DUF) is higher 19.16% to $15.55. Duff & Phelps Corporation (Duff & Phelps) is a provider of independent financial advisory and investment banking services. The Company provides solutions in the areas of valuation, transactions, financial restructuring, alternative assets, disputes and taxation. The Company operates in the areas of Amsterdam, Atlanta, Austin, Beijing, Boston, Chicago, Dallas, Denver, Detroit, Houston, London, Los Angeles, Morristown, Munich, New York, Paris, Philadelphia, Plano, San Francisco, Seattle, Shanghai, Silicon Valley, Tokyo, Toronto and Washington, D.C.

Is DUF Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here

Hovnanian Enterprises, Inc. (NYSE:HOV) is higher 1.41% to $6.82. Hovnanian Enterprises, Inc. (Hovnanian) designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, mid-rise condominiums, urban infill and active adult homes in planned residential developments. The Company consists of two distinct operations: homebuilding and financial services. Its homebuilding operations consist of six segments: Northeast,including New Jersey and Pennsylvania; Mid-Atlantic, including Delaware, Maryland, Virginia, West Virginia, and Washington, D.C; Midwest, including Illinois, Minnesota and Ohio; Southeast, including Florida, Georgia, North Carolina and South Carolina; Southwest, including Arizona and Texas, and West, including California.

Can HOV Rebound After The Recent Slump and Investors Can Make Money? Find Out Here

ARMOUR Residential REIT, Inc. (NYSE:ARR) among the losers and the stock fell 0.15% to $6.46. ARMOUR Residential REIT, Inc. (ARMOUR) is an externally-managed Maryland company managed by ARMOUR Residential REIT, Inc. (ARRM). ARMOUR invests primarily in hybrid adjustable rate, adjustable rate and fixed rate residential mortgage backed securities issued or guaranteed by a United States Government-sponsored entity (GSE), such as the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac), or guaranteed by the Government National Mortgage Administration, a United States Government corporation (Ginnie Mae) (collectively, Agency Securities).

Is ARR Ready To Move Back To New Highs This Year? Find Out Here

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is lower 0.45% to $8.81. Arena Pharmaceuticals, Inc. (Arena) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors (GPCRs), in four therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. After completing various studies, analyses and other activities in response to the lorcaserin CRL, in December 2011, the Company resubmitted the lorcaserin NDA.

Is ARNA Ready To Move Back To New Highs This Year? Find Out Here

Disclaimer
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information:
Winning Media LLC
1-800-411-7716
ir@AnotherWinningTrade.com